Zacks Small Cap Research on MSN

RNAZ: Introducing RNA therapeutics

By John Vandermosten, CFA NASDAQ: RNAZ READ THE FULL RNAZ RESEARCH NOTE RNA Oncology Ribonucleic acid (RNA) oncology is a specialized field in the cancer space that focuses on using RNA-based ...
In a review article, researchers have uncovered compelling evidence that long noncoding RNAs—molecules once dismissed as "junk DNA"—may hold the key to revolutionizing how we diagnose and treat mood ...
Northwestern Medicine scientists have discovered new insights into the production and regulation of a class of noncoding RNAs and how alterations in their signatures diversify and modulate the ...
Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with night blindness in youth and progresses to tunnel vision as ...
When a gene produces too much protein, it can have devastating consequences on brain development and function. Patients with an overproduction of protein from the chromodomain helicase DNA binding ...
Various sayings equate going fast with going alone. But none of them apply to the gene expression journey described by a research team from the University of Göttingen. The team, led by Heike Krebber, ...
Breakthrough discovery of fungal long non-coding RNA attack mechanism could enable greener, broad-spectrum disease-resistant ...
Terc-53 functions as a molecular scaffold bringing together Hmmr and Trim25, accelerating Hmmr’s ubiquitination-mediated degradation, which consequently leads to neuroinflammation and cognition ...